55289-15-1

Basic information

• Product Name: methyl 6-bromo-3-hydroxy-2-methylbenzoate
• Synonyms: methyl 6-bromo-3-hydroxy-2-methylbenzoate
• CAS NO: 55289-15-1
• Molecular Formula: C₉H₉BrO₃
• Molecular Weight: 245.08
• Mol File: 55289-15-1.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 326.2±37.0 °C(Predicted)
• Appearance: /
• Density: 1.548±0.06 g/cm3(Predicted)
• PKA: 8.94±0.23(Predicted)
• CAS DataBase Reference: methyl 6-bromo-3-hydroxy-2-methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 6-bromo-3-hydroxy-2-methylbenzoate(55289-15-1)
• EPA Substance Registry System: methyl 6-bromo-3-hydroxy-2-methylbenzoate(55289-15-1)

Safety Data

• Hazardous Substances Data: 55289-15-1(Hazardous Substances Data)

Upstream product

• 603-80-5 3-hydroxy 2-methylbenzoic acid 
• 55289-04-8 3-hydroxy-2-methylbenzonitrile 
• 3260-87-5 3-chloro-o-cresol 
• 1975-50-4 2-methyl-3-nitrobenzic acid 
• 59382-59-1 2-methyl-3-nitro-benzoic acid methyl ester 
• 55289-05-9 methyl 3-hydroxy-2-methylbenzoate 

Downstream Products

• 55289-16-2 methyl 6-bromo-3-methoxy-2-methylbenzoate 
• 948837-59-0 C₁₅H₂₃O₃BrSi 
• 1616290-17-5 4-{[2-(benzyloxy)-4,6-dimethylpyridin-3-yl]methyl}-7-ethoxy-6-methyl-3,4-dihydro-1,4-benzoxazepin-5(2H)-one 
• 1616290-15-3 N-{[2-(benzyloxy)-4,6-dimethylpyridin-3-yl]methyl}-3-ethoxy-6-hydroxy-N-(2-hydroxyethyl)-2-methylbenzamide 
• 1616290-13-1 3-ethoxy-6-hydroxy-2-methylbenzoic acid 
• 1616290-12-0 methyl 6-bromo-3-ethoxy-2-methylbenzoate 
• 55289-21-9 4-methoxy-3-methyl-phthalic acid 
• 55289-18-4 methyl 6-cyano-3-methoxy-2-methylbenzoate 
• 55289-17-3 6-bromo-3-methoxy-2-methylbenzoic acid 
• 948837-54-5 C₃₁H₅₂O₅Si₂ 
• 948837-53-4 C₃₁H₅₄O₄Si₂ 
• 948837-61-4 C₂₇H₄₂O₅Si 
• 948837-52-3 C₃₀H₄₆O₅Si 
• 948837-51-2 C₂₁H₃₁O₃SiBr 

Relevant articles and documents

ARYL AND HETEROARYL FUSED LACTAMS

This invention relates to compounds of general formula (I) in which R1, R2, U, V, L, M, R5, m, X, Y and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.

Studies toward the total synthesis of nakiterpiosin: construction of the CDE ring system by a transannular Diels-Alder strategy

The transannular Diels-Alder (TADA) reaction was applied to the synthesis of the CDE ring system of nakiterpiosin (1). Tetracyclic compound 25 may be a key intermediate in the total synthesis of 1.